Abstract

Get full access to this article
View all access options for this article.
References
1.
Rhee
C
,
Broadbent
AM
. Palliation and liver failure: Palliative medications dosing guidelines . J Palliat Med , 2007 ; 10 :677 –685 .
2.
Zichterman
A
. Opioid pharmacology, considerations in pain management . US Pharmacist 2007 . www.uspharmacist.com/continuing_education/ceviewtest/lessonid/105473/. 2012 July 19.
3.
Davis
M
. Cholestasis and endogenous opioids: Liver disease and exogenous opioid pharmacokinetics . Clin Pharmacokinet , 2007 ; 46 :825 –850 .
4.
Johnson
SJ
. Opioid safety in patients with renal or hepatic dysfunction . Pain Treatment Topics 2007 . pain-topics.org/pdf/Opioids-Renal-Hepatic-Dysfunction.pdf#search=“opioidsand liver failure”.2012 July 3.
5.
Tegeder
I
,
Lotsch
J
,
Geisslinger
G
. Pharmacokinetics of opioids in liver disease . Clin Pharmacokinet , 1999 ; 37 :17 –40 .
